Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes - Lambers Heerspink, H. J.; de Zeeuw, D.; Wie, L.; Leslie, B.; List, J. (Diabetes, obesity & metabolism, 2013)
Keywords: Adolescent; Adult; Aged; Antidiabetics; Benzhydryl Compounds; Blindness; Blood Glucose - metabolism; Blood Pressure; Body weight; dapagliflozin; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - epidemiology; Diuretics; Diuretics - administration & dosage; Diuretics - therapeutic use; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular filtration rate; Glucose; Glucose transporter; Glucosides - administration & dosage; Glucosides - therapeutic use; HbA1c; Hemoglobin; Humans; Hydrochlorothiazide; Hydrochlorothiazide - administration & dosage; Hydrochlorothiazide - therapeutic use; Hyperglycemia; Hypoglycemic Agents - administration & dosage; Hypoglycemic Agents - therapeutic use; Male; Middle Aged; Original; Placebos; Plasma; Renal function; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; type 2 diabetes; Weight Loss - drug effects; blood pressure; renal function; type 2 diabetes; HbA1c; dapagliflozin